GeoVax Labs, Inc.
GOVXNasdaqCIK 832489HealthcareFiscal year ends Dec 31
Reports and events: 353 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2713:00 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-26-033610 |
| 2026-10-2709:00 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-033566 |
| 2026-09-1716:06 ET | S-1 | Registration statement | 0001437749-26-030676 |
| 2026-09-1016:41 ET | DEF 14A | Proxy statementPeriod 2026-10-27 | 0001437749-26-030089 |
| 2026-09-1016:35 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-030085 |
| 2026-08-2816:16 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001437749-26-029184 |
| 2026-08-2816:09 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001437749-26-029181 |
| 2026-07-2716:34 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001437749-26-024523 |
| 2026-07-2716:33 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-024522 |
| 2026-07-1016:04 ET | 8-K | 3.01 Delisting notice | 0001437749-26-023320 |
| 2026-06-1716:32 ET | 8-K | 5.07 Shareholder vote results | 0001437749-26-020984 |
| 2026-05-2609:00 ET | S-1 | Registration statement | 0001437749-26-018320 |
| 2026-05-1917:04 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-017809 |
| 2026-05-1416:23 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-017070 |
| 2026-05-1416:07 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001437749-26-017048 |
| 2026-05-0716:27 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001437749-26-015613 |
| 2026-04-2716:10 ET | DEF 14A | Proxy statementPeriod 2026-06-17 | 0001437749-26-013468 |
| 2026-04-1617:41 ET | S-1 | Registration statement | 0001437749-26-012440 |
| 2026-04-1617:40 ET | S-1 | Registration statement | 0001437749-26-012439 |
| 2026-04-1517:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-012435 |
| 2026-04-1515:57 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001437749-26-012377 |
| 2026-03-3117:15 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001437749-26-010733 |
| 2026-02-1717:21 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-004392 |
| 2026-01-1216:31 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001437749-26-001113 |
| 2025-12-2216:35 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-038547 |
| 2025-12-1217:26 ET | S-1 | Registration statement | 0001437749-25-037757 |
| 2025-11-2616:05 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-25-036447 |
| 2025-11-1317:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-034903 |
| 2025-11-1316:03 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001437749-25-034811 |
| 2025-10-1716:41 ET | S-1 | Registration statement | 0001437749-25-031281 |
| 2025-10-1416:29 ET | DEF 14A | Proxy statementPeriod 2025-11-26 | 0001437749-25-030934 |
| 2025-09-3016:43 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-030125 |
| 2025-08-0116:31 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001437749-25-024389 |
| 2025-07-2917:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-023689 |
| 2025-07-2816:11 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001437749-25-023651 |
| 2025-07-0216:22 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-021990 |
| 2025-06-2617:29 ET | S-1/A | Registration statement, amended | 0001437749-25-021364 |
| 2025-06-1616:38 ET | S-1 | Registration statement | 0001437749-25-020507 |
| 2025-06-0516:40 ET | 8-K | 5.07 Shareholder vote results | 0001437749-25-019563 |
| 2025-05-0116:58 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-014147 |
| 2025-05-0116:01 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001437749-25-014083 |
| 2025-04-1416:28 ET | 8-K | 1.02 Termination of a material agreement | 0001437749-25-011926 |
| 2025-04-1416:11 ET | DEF 14A | Proxy statementPeriod 2025-06-05 | 0001437749-25-011916 |
| 2025-03-2816:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-009859 |
| 2025-03-2716:05 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001437749-25-009614 |
| 2025-03-2516:14 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-009141 |
| 2025-01-2216:01 ET | 8-K | 5.07 Shareholder vote results | 0001437749-25-001556 |
| 2024-12-1816:09 ET | 8-K | 8.01 Other events | 0001437749-24-037842 |
| 2024-11-1816:02 ET | 8-K | 3.01 Delisting notice | 0001437749-24-035609 |
| 2024-11-1316:13 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-034910 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 13:01 ET. Listed shows no prices and gives no investment advice.